Patents for A61P 33 - Antiparasitic agents (21,787) |
---|
08/04/2005 | US20050171047 Immunostimulatory nucleic acid molecules |
08/04/2005 | US20050169971 Pellet or tablet attractive to livestock masking a drug such as benazepril; animal feed substrate, intimately mixed with coated particles of a carrier material and an active ingredient casing that is coated by a masking protective layer |
08/04/2005 | US20050169928 Antibodies which bind to proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes |
08/03/2005 | EP1559321A1 Mixed compositions for controlling parasitic insects |
08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
08/03/2005 | EP1196439B1 Compounds exhibiting an antibiotic activity |
08/03/2005 | CN1650020A Means and methods for the production of adenovirus vectors |
08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
08/03/2005 | CN1649890A Anti-protozoal vaccine |
08/03/2005 | CN1649874A Antiparasitic artemisinin derivatives (endoperoxides) |
08/03/2005 | CN1649603A Aqueous compositions containing metronidazole |
08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
08/03/2005 | CN1649579A N-acylaminoacetonitrile derivatives and their use for controlling parasites |
08/03/2005 | CN1649508A Use of fermented wheat-germ in feeding and veterinary practice |
08/02/2005 | US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases |
08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
08/02/2005 | US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof |
08/02/2005 | US6924092 Testing prospective herbicides and parasiticides by incubating a substance with a monogalactodiacyl synthase or plastidal membrane products to select enzyme inhibitors; apicomplex parasites; antimalarial agents; coccidiosis;toxoplasmosis |
08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
07/28/2005 | WO2005068429A1 Derivatives of pyridine and quinoline |
07/28/2005 | WO2005067951A1 Botanical extract composition |
07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
07/28/2005 | US20050165077 Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage |
07/28/2005 | US20050165068 Compounds, in particularly of urea derivatives or esters of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
07/28/2005 | US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide |
07/28/2005 | US20050163862 Suppressing cytokine secretion with such as sodium selenite; by the reduction in extra- and intracellular oxidative stress |
07/28/2005 | CA2553953A1 Therapeutic use of quinonoid derivatives of cannabinoids |
07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
07/27/2005 | EP1556007A2 Substituted tetracycline compounds for the treatment of malaria |
07/27/2005 | EP1276376B1 Active substance combinations with insecticidal and acaricidal properties |
07/27/2005 | EP0935462B1 Photopheresis treatment of leukocytes |
07/27/2005 | CN1646152A Mannose binding lectin and uses thereof |
07/27/2005 | CN1646131A Novel compounds |
07/27/2005 | CN1646104A Dry granulated formulations of azithromycin |
07/27/2005 | CN1644214A YG and YGG used as maintenance and improvement of immunoreaction |
07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
07/26/2005 | US6921763 Protein kinase inhibitors |
07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
07/21/2005 | WO2005065063A2 Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
07/21/2005 | US20050158277 Method to genetate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production |
07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
07/20/2005 | EP1553970A1 Treatment of allergic conditions by use of il 21 |
07/20/2005 | EP1286673B8 Ligands of integrin receptors |
07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
07/20/2005 | EP0929677B1 Recombinant method for preparing a complete malaria antigen gp190/msp1 |
07/20/2005 | CN1643382A A cytocapacity test |
07/20/2005 | CN1642966A Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
07/20/2005 | CN1640493A Leptospira vaccine |
07/20/2005 | CN1640492A 一种钩端螺旋体外膜蛋白疫苗 One kind of Leptospira outer membrane protein vaccine |
07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
07/19/2005 | US6919090 Active substance combinations with insecticidal and acaricidal properties |
07/14/2005 | WO2005062748A2 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
07/14/2005 | US20050154215 Extraction from Zanthoxylum naranjillo leaves; nuclear magnetic resonance; for treatment of Chaga's disease |
07/14/2005 | US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis |
07/14/2005 | US20050154003 Containing a 1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinoline ring, e.g., {10-[(E)-(ter-butoxyimino)methyl]-3-ethyl-1,13-dioxo-11,13-dihydro-1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinolin-3-yl}acetic acid; topoisomerase I inhibitors used to treat cancer |
07/14/2005 | US20050153997 Fredericamycin derivatives |
07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
07/14/2005 | CA2550344A1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof |
07/13/2005 | EP1552848A1 Compositions against chicken coccidiosis |
07/13/2005 | EP1552844A1 Botanical extract composition |
07/13/2005 | EP1551445A2 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
07/13/2005 | EP1551390A1 Levamisole, avermectins or similar in pyrrolidone solvent |
07/13/2005 | EP1551375A1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
07/13/2005 | EP1551330A1 Improvements in delivery technology |
07/13/2005 | EP1551228A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
07/13/2005 | EP1551221A2 Nucleic acid compositions for stimulating immune responses |
07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
07/13/2005 | EP0938308B1 Antiparasitic agents |
07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
07/13/2005 | CN1638770A Composition and potentiating method |
07/13/2005 | CN1638762A Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
07/13/2005 | CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
07/13/2005 | CN1637011A Avermectin derivatives |
07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
07/13/2005 | CN1210064C Compositions for the treatment of coccidiosis |
07/13/2005 | CN1210040C Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
07/12/2005 | CA2351429C 13-membered azalides and their use as antibiotic agents |
07/12/2005 | CA2341739C Quinolin-2-one derivatives useful as anticancer agents |
07/07/2005 | US20050148628 Treatment of malaria with mixtures of artesunate and mefloquine for three days and blister packs of medicine |
07/07/2005 | US20050148619 Sulfonamido ether substituted imidazoquinolines |
07/07/2005 | US20050148569 Targeted oxidative therapeutic formulation |
07/07/2005 | US20050148568 Treating sarcocystis protozoa infected horses; peroxidic species from oxidation of such as geraniol, penetrating solvent;, metal chelated dye and aromatic redox compound; activating with ionizing radiation |
07/07/2005 | US20050148566 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
07/07/2005 | US20050148520 Avermectin derivatives |
07/07/2005 | US20050148503 Comprises erythropoietin as active ingredient; for treatment of anemia, trypanosomiasis, or malaria |
07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
07/06/2005 | EP1549761A1 Methods and compositions for the modification of nucleic acids |
07/06/2005 | EP1549291A1 Injection formulation |
07/06/2005 | EP1490315A4 Controlling chemical reactions by spectral chemistry and spectral conditioning |
07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
07/06/2005 | CN1635979A IL-8 receptor antagonists |
07/06/2005 | CN1635912A Targeted delivery of drugs for the treatment of parasitic infections |